rabeprazole
1.In most instances, the relationship to rabeprazole sodium was unclear.
2.Rabeprazole is indicated for short term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosie or ulceratie gastroesophageal reflux disease (GERD).
3.Patients in A group were given rabeprazole 10 mg qd , mosapride 5 mg tid for 2 weeks, patients in B group were given the same medicines as group A in first week and avelox 0.4 g qd was added in the second week.
4.Post-Marketing Aderse Eents: Additional aderse eents reported from worldwide marketing experience with rabeprazole sodium are: , coma and hyperammonemia, jaundice, rhabdomyolysis, disorientation and delirium, anaphylaxis, angioedema, bullous and other drug eruptions of the skin, interstitial pneumonia, interstitial nephritis, TSH eleations.
